Goldman Sachs’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.61M Sell
181,426
-85,987
-32% -$1.24M ﹤0.01% 3245
2025
Q1
$1.85M Buy
267,413
+96,333
+56% +$665K ﹤0.01% 3414
2024
Q4
$908K Buy
171,080
+26,053
+18% +$138K ﹤0.01% 3970
2024
Q3
$529K Buy
145,027
+69,559
+92% +$254K ﹤0.01% 4086
2024
Q2
$206K Sell
75,468
-116,757
-61% -$319K ﹤0.01% 4358
2024
Q1
$669K Buy
+192,225
New +$669K ﹤0.01% 3838
2022
Q4
Sell
-13,364
Closed -$16K 5381
2022
Q3
$16K Sell
13,364
-309,714
-96% -$371K ﹤0.01% 5204
2022
Q2
$540K Sell
323,078
-32,280
-9% -$54K ﹤0.01% 4328
2022
Q1
$874K Sell
355,358
-75,768
-18% -$186K ﹤0.01% 4209
2021
Q4
$1.61M Buy
431,126
+78,834
+22% +$295K ﹤0.01% 3646
2021
Q3
$2.21M Sell
352,292
-28,830
-8% -$181K ﹤0.01% 3405
2021
Q2
$3.76M Sell
381,122
-86,191
-18% -$850K ﹤0.01% 3001
2021
Q1
$4.37M Buy
467,313
+366,715
+365% +$3.43M ﹤0.01% 2763
2020
Q4
$483K Buy
100,598
+14,415
+17% +$69.2K ﹤0.01% 3843
2020
Q3
$345K Buy
86,183
+33,908
+65% +$136K ﹤0.01% 3832
2020
Q2
$240K Buy
52,275
+6,163
+13% +$28.3K ﹤0.01% 3917
2020
Q1
$150K Buy
46,112
+14,091
+44% +$45.8K ﹤0.01% 4039
2019
Q4
$138K Buy
32,021
+3,159
+11% +$13.6K ﹤0.01% 4079
2019
Q3
$114K Buy
28,862
+7,988
+38% +$31.6K ﹤0.01% 4033
2019
Q2
$97K Buy
20,874
+1,640
+9% +$7.62K ﹤0.01% 4000
2019
Q1
$81K Buy
+19,234
New +$81K ﹤0.01% 4034
2018
Q2
Sell
-229,405
Closed -$964K 4343
2018
Q1
$964K Buy
229,405
+214,439
+1,433% +$901K ﹤0.01% 3206
2017
Q4
$88K Buy
+14,966
New +$88K ﹤0.01% 3979
2017
Q3
Sell
-182,633
Closed -$698K 4436
2017
Q2
$698K Buy
182,633
+163,817
+871% +$626K ﹤0.01% 3335
2017
Q1
$51K Hold
18,816
﹤0.01% 4216
2016
Q4
$62K Hold
18,816
﹤0.01% 4201
2016
Q3
$56K Sell
18,816
-130,118
-87% -$387K ﹤0.01% 4288
2016
Q2
$617K Buy
+148,934
New +$617K ﹤0.01% 3203